ConductScience.org, home

Paper14435563

Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects.

QUINN GP and 2 others. J Pharmacol Exp Ther, 1959. Cited by 231 papers, by iCite.

Cite this record

ConductScience Library. Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects. Papers, record 14435563. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14435563

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects.
PubMed
Journal
J Pharmacol Exp Ther
PubMed
Year
1959
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
231
iCite
Revised in PubMed
2022-03-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1QUINN GPG P
2SHORE PAP A
3BRODIE BBB B

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hypnotics and SedativesMajor topic
ReserpineMajor topic
TetrabenazineMajor topic
Tranquilizing AgentsMajor topic

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.

PMIDTitleJournalYearIn PapersSource
41452009Deciphering Ibogaine's Matrix Pharmacology: Multiple Transporter Modulation at Serotonin Synapses.J Am Chem Soc2026https://conductscience.org/library/papers/41452009PubMed
39618418How antipsychotics work in schizophrenia: a primer on mechanisms.CNS Spectr2024https://conductscience.org/library/papers/39618418PubMed
36120044Stereoselective Synthesis of Benzo[a]quinolizidines via Aerobic DDQ-Catalyzed Allylation and Reductive Cyclization.ACS Omega2022https://conductscience.org/library/papers/36120044PubMed
30237454Therapeutic approaches to Huntington disease: from the bench to the clinic.Nat Rev Drug Discov2018https://conductscience.org/library/papers/30237454PubMed
28782244Using the affective bias test to predict drug-induced negative affect: implications for drug safety.Br J Pharmacol2017https://conductscience.org/library/papers/28782244PubMed
26000211Effect of tetrabenazine on motor function in patients with huntington disease.Neurol Ther2012https://conductscience.org/library/papers/26000211PubMed
22778401Brain dopamine and serotonin differ in regulation and its consequences.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22778401PubMed
22133328Tetrabenazine: for chorea associated with Huntington's disease.CNS Drugs2011https://conductscience.org/library/papers/22133328PubMed
20135628Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry.Med Res Rev2011https://conductscience.org/library/papers/20135628PubMed
19381278Tetrabenazine in the treatment of Huntington's disease.Neuropsychiatr Dis Treat2007https://conductscience.org/library/papers/19381278PubMed
19116624Tetrabenazine.Nat Rev Drug Discov2009https://conductscience.org/library/papers/19116624PubMed
18544005Tourette's syndrome and role of tetrabenazine: review and personal experience.Clin Drug Investig2008https://conductscience.org/library/papers/18544005PubMed
14482990The inactivation of 5-hydroxytryptamine by blood platelets in mental deficiency with elevated serum 5-hydroxytryptamine.Psychopharmacologia1962https://conductscience.org/library/papers/14482990PubMed
14429629Inhibition of 5-hydroxytryptamine release from blood platelets by N2-isopropyl isonicotinic acid hydrazide.Experientia1960https://conductscience.org/library/papers/14429629PubMed
14429628Increase of free 5-hydroxytryptamine in blood plasma by reserpine and a benzoquinolizine derivative.Experientia1959https://conductscience.org/library/papers/14429628PubMed
14230236ON THE MECHANISM OF ACTION OF CHLORPROMAZINE IN RELEASING 5-HYDROXYTRYPTAMINE FROM BLOOD PLATELETS IN VITRO.Naunyn Schmiedebergs Arch Exp Pathol Pharmakol1964https://conductscience.org/library/papers/14230236PubMed
14151552ENHANCED DEPRESSANT EFFECT OF TETRABENAZINE AFTER REPEATED ADMINISTRATION.Psychopharmacologia1964https://conductscience.org/library/papers/14151552PubMed
14066151THE INCREASE IN THE TOXICITY OF YOHIMBINE INDUCED BY IMIPRAMINE AND OTHER DRUGS IN MICE.Br J Pharmacol Chemother1963https://conductscience.org/library/papers/14066151PubMed
13889332[Inhibitory effect of tetrabenazine on the adrenal cortex-influencing action of reserpine].Experientia1962https://conductscience.org/library/papers/13889332PubMed
6310099Reserpine has a direct action as a calcium antagonist on mammalian smooth muscle cells.J Physiol1983https://conductscience.org/library/papers/6310099PubMed

See all 38 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14435563

GET https://conductscience.org/api/papers/v1/14435563/cited_by?page=2